Publications - Supplementary Data

Publication	Supplementary
Colombo M, Kruhoeffer M, Gregersen S, Agger A, Jeppesen P, Orntoft T, Hermansen K. Energy restriction prevents the development of type 2 diabetes in Zucker diabetic fatty rats: coordinated patterns of gene expression for energy metabolism in insulin-sensitive tissues and pancreatic islets determined by oligonucleotide microarray analysis. Metabolism. 2006 Jan;55(1):43-52. PubMed	Suppl tables Suppl figures
Colombo M, Gregersen S, Kruhoeffer M, Agger A, Xiao J, Jeppesen PB, Orntoft T, Ploug T, Galbo H, Hermansen K. Prevention of hyperglycemia in Zucker diabetic fatty rats by exercise training: effects on gene expression in insulin-sensitive tissues determined by high-density oligonucleotide microarray analysis, Metabolism, 54: 1571-1581, 2005. PubMed	Suppl table 1 Suppl table 2 Suppl table 3 Suppl table 4 Suppl table 5 Suppl table 6
Aaboe M, Marcussen N, Jensen KM, Thykjaer T, Dyrskjot L, Orntoft TF. Gene expression profiling of noninvasive primary urothelial tumours using microarrays. Br J Cancer. 2005 Nov 1; [Epub ahead of print] PubMed	Suppl table 1-3 (zip)
Dyrskjøt L, Zieger K, Kruhøffer M, Thykjaer T, Jensen JL, Primdahl H, Aziz N, Marcussen N, Møller K and Ørntoft TF. A molecular signature in superficial bladder carcinoma predicts clinical outcome. Clinical Cancer Research. 2005. June 1, 11 (11): PubMed	Suppl data Microarray expression data annotation dec 2004
Koed, K., Wiuf,C., Christensen, L.L., Wikman, F., Zieger, K., Møller, K., von der Maase, H., Ørntoft, T.F. High-density single nucleotide polymorphism array defines novel stage and location-dependent allelic imbalances in human bladder tumors. Cancer Research. 2005. 65 (1):34-45.PubMed	Figure 1 Figure 2 Suppl material
Andersen C.L., Ledet-Jensen J., Ørntoft T.: Normalization of real-time quantitative RT-PCR data: a model based variance estimation approach to identify genes suited for normalization - applied to bladder- and colon-cancer data-sets. Cancer Research.2004 (64): 5245-5250. PubMed	NormFinder software Express Raw data (txt) Figure 1 and 2 Supplementary information
Dyrskjot,L., Kruhoffer,M., Thykjaer,T., Marcussen,N., Jensen,J.L., Moller,K., Orntoft,T.F. Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res.. 64(11): 4040-4048. 2004. PubMed	supplementary information GEO data
Dyrskjot,L., Thykjaer,T., Kruhoffer,M., Jensen,J.L., Marcussen,N., Hamilton-Dutoit,S., Wolf,H., Orntoft,T.F. Identifying distinct classes of bladder carcinoma using microarrays. Nat.Genet.. 33(1): 90-96. 2003. PubMed	GEO data: GSE88 GSE89
Primdahl,H., Wikman,F.P., von der,Maase H., Zhou,X.G., Wolf,H., Orntoft,T.F. Allelic imbalances in human bladder cancer: genome-wide detection with high-density single-nucleotide polymorphism arrays. J.Natl.Cancer Inst.. 94(3): 216-223. 2002.PubMed	data
Thykjaer,T., Workman,C., Kruhoffer,M., Demtroder,K., Wolf,H., Andersen,L.D., Frederiksen,C.M., Knudsen,S., Orntoft,T.F. Identification of gene expression patterns in superficial and invasive human bladder cancer. Cancer Res.. 61(6): 2492-2499. 2001. PubMed	data
Olesen,S.H., Thykjaer,T., Orntoft,T.F. Mitotic checkpoint genes hBUB1, hBUB1B, hBUB3 and TTK in human bladder cancer, screening for mutations and loss of heterozygosity. Carcinogenesis. 22(5): 813-815. 2001.PubMed	data
Wikman,F.P., Lu,M.L., Thykjaer,T., Olesen,S.H., Andersen,L.D., Cordon-Cardo,C., Orntoft,T.F. Evaluation of the performance of a p53 sequencing microarray chip using 140 previously sequenced bladder tumor samples. Clin.Chem.. 46(10): 1555-1561. 2000. PubMed	data
Celis,J.E., Kruhoffer,M., Gromova,I., Frederiksen,C., Ostergaard,M., Thykjaer,T., Gromov,P., Yu,J., Palsdottir,H., Magnusson,N., Orntoft,T.F. Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics. FEBS Lett.. 480(1): 2-16. 2000. PubMed	FEBS Letter